Western Sky Medical Research
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- -
- Market Cap
- -
Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis
Phase 4
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-10-19
- Last Posted Date
- 2018-05-18
- Lead Sponsor
- Western Sky Medical Research
- Target Recruit Count
- 40
- Registration Number
- NCT00997620
Comparing Bronchodilation of Symbicort With and Without Valved Holding Chamber (Aerochamber Plus)
Phase 4
Completed
- Conditions
- Asthma
- Interventions
- Drug: pMDI budesonide/formotrol 160/4.5 is in group 1Device: Symbicort 160/4.5 plus Aerochamber Plus included in group 2
- First Posted Date
- 2009-06-08
- Last Posted Date
- 2020-08-13
- Lead Sponsor
- Western Sky Medical Research
- Target Recruit Count
- 16
- Registration Number
- NCT00915538
- Locations
- 🇺🇸
Western Sky Medical Research, El Paso, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath